Katarzyna P. K.
- Country
- Poland
- Department
- Klinika Dermatologii, Dermatologii Dziecięcej i Onkologicznej Uniwersytetu Medycznego
Research Overview
- A Phase 1 Randomized, Double‑Blind, Placebo‑Controlled Study of BBT001 in Healthy Volunteers and Adults with Atopic Dermatitis
- Efficacy and Safety Evaluation of Vilobelimab in Ulcerative Pyoderma Gangrenosum: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- Efficacy and Safety Evaluation of Bimekizumab Versus Ustekinumab in Pediatric Patients with Moderate to Severe Plaque Psoriasis
Data & Insights
Has run more than one trial at 10 of 62 partner sites.
Specializations
Dermatology and inflammatory skin disease
The investigator’s clinical research includes atopic dermatitis, moderate to severe plaque psoriasis, and ulcerative pyoderma gangrenosum, with attention to immune-mediated skin disease and targeted anti-inflammatory treatment.
- Atopic dermatitis
- Moderate to severe plaque psoriasis
- Pyoderma gangrenosum
Work in this area also reflects interest in dermatologic conditions requiring advanced immunomodulatory therapy and novel biologic strategies.
Cardiovascular disease and acute coronary syndromes
Her trial portfolio covers acute myocardial infarction, acute coronary syndrome, atherosclerotic cardiovascular disease, and broader cardiovascular risk reduction, including prevention of major adverse cardiac events.
- Acute coronary syndrome
- Myocardial infarction
- Atherosclerotic cardiovascular disease
Additional interests include lipid-lowering therapy, familial hypercholesterolaemia, and treatment approaches for patients at elevated cardiovascular risk.
Heart failure and structural heart disease
Her research landscape includes heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, heart failure with mildly reduced ejection fraction, and hypertrophic cardiomyopathy.
- Heart failure
- Hypertrophic cardiomyopathy
- Systemic inflammation
The clinical focus extends to acute heart failure and inflammatory pathways linked to worsening cardiac function.
Pulmonary hypertension and pulmonary vascular disease
A substantial part of the investigator’s activity centers on pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, and combined postcapillary and precapillary pulmonary hypertension related to HFpEF.
- Pulmonary arterial hypertension
- Pulmonary hypertension associated with interstitial lung disease
- Pulmonary vascular resistance
This area also includes interest in pulmonary hemodynamics, exercise limitation, and therapies for advanced pulmonary vascular disease.
HIV infection and infectious respiratory disease
Her clinical trial involvement also spans HIV-1 infection and treatment optimization in both treatment-naïve and virologically suppressed patients.
- HIV-1 infection
- Antiretroviral therapy
- Severe viral lung infections
Related interests include therapeutic options for hospitalized patients with viral lung infection requiring respiratory support.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.